2 Paid Clinical Research Studies in Daphne, Alabama
Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) versus placebo in combination with neoadjuvant (pre-surgery) chemotherapy and adjuvant (po
📍 Southern Cancer Center, PC ( Site 8003) — Daphne, Alabama
💵 Study participants will receive 8 cycles of neoadjuvant study treatment and then will undergo surgery for their breast c
View Study & Checklist ➔BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
This is an open-label, randomized study of BMS-986489 (atigotatug + nivolumab fixed-dose combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants
📍 Southern Cancer Center — Daphne, Alabama
💵 Participants will receive concurrent chemotherapy and radiotherapy according to standard guidelines for treatment of LS-
View Study & Checklist ➔